3,4-dihydroxyphenylacetic acid has been researched along with thalidomide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Flohé, L; Günzler, WA; Hennies, HH | 1 |
| Boireau, A; Bordier, F; Dubédat, P; Impérato, A; Pény, C | 1 |
| Cherng, CG; Lin, KY; Lin, LC; Lu, RB; Yang, FR; Yu, L | 1 |
4 other study(ies) available for 3,4-dihydroxyphenylacetic acid and thalidomide
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Influence of supidimide on brain neurotransmitter systems of rats and mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Aminobutyrate Transaminase; Adenylyl Cyclases; Animals; Binding, Competitive; Brain; Brain Chemistry; Catechol O-Methyltransferase; Dopamine; Electroshock; gamma-Aminobutyric Acid; Hydroxyindoleacetic Acid; In Vitro Techniques; Male; Mice; Monoamine Oxidase; Neurotransmitter Agents; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, GABA-A; Serotonin; Species Specificity; Spiperone; Thalidomide; Tryptophan; Tyrosine 3-Monooxygenase | 1984 |
Thalidomide reduces MPTP-induced decrease in striatal dopamine levels in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Inflammatory Agents; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Homovanillic Acid; Hypnotics and Sedatives; Immunosuppressive Agents; Male; Mice; Mice, Inbred C57BL; Parkinson Disease; Thalidomide | 1997 |
Memantine abolishes the formation of cocaine-induced conditioned place preference possibly via its IL-6-modulating effect in medial prefrontal cortex.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Anesthetics, Local; Animals; Cocaine; Conditioning, Operant; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Immunosuppressive Agents; Interleukin-1beta; Interleukin-6; Male; Memantine; Mice; Mice, Inbred C57BL; Motor Activity; Nucleus Accumbens; Prefrontal Cortex; Thalidomide; Tumor Necrosis Factor-alpha | 2011 |